KUALA LUMPUR (Apr 23): TMC Life Sciences Bhd, controlled by Singapore billionaire Peter Lim, climbed as much as 3.5 sen or 5% after the healthcare services provider reported higher third quarter net profit from a year earlier.
At 11.19 am, TMC (fundamental: 2.5; valuation: 0.5) pared gains to trade at 69.5 sen with some six million shares changing hands.
The FBM KLCI was down 2.95 points or 0.16%.
TMC shares have risen 24% this year, outperforming the KLCI's 5% gain.
In a filing with Bursa Malaysia yesterday, TMC said it posted a net profit of RM2.91 million for the third quarter ended Feb 28, 2015 versus RM1.74 million a year earlier. Revenue was higher at RM26.41 million compared with RM21.72 million.
For the nine months, net profit rose to RM5.94 million, from RM3.78 million a year earlier while revenue was higher at RM74.68 million compared to RM62.74 million.
Billionaire Peter Lim owns 68.47% in TMC. His stake is held via Sasteria (M) Pte Ltd.
Other notable TMC shareholders include Berjaya Corp Bhd (fundamental: 0.9; valuation: 2).
(Note: The Edge Research's fundamental score reflects a company’s profitability and balance sheet strength, calculated based on historical numbers. The valuation score determines if a stock is attractively valued or not, also based on historical numbers. A score of 3 suggests strong fundamentals and attractive valuations.)